Inscriere cercetatori

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

Domenii publicaţii > Ştiinţe medicale + Tipuri publicaţii > Articol în revistã ştiinţificã

Autori: Abdulkadyrov K, Afanasiev B, Aguayo-Gonzalez A, Andre M, Belada D, Ben-Yehuda D, Bezares RF, Biakhov MY, Bolam S, Borbenyi Z, Bron D, Buckstein R, Bumbea H, Caballero Barrigon MD, Campos LT, Cantonetti M, Capra Zanella ME, Christiansen NP, Cohen GL, Colit

Editorial: Lancet Oncology, 12(8), p.773-84, 2011.

Rezumat:

Cuvinte cheie: oncologie // oncology journal